Karel Dicke, M.D., Ph.D.

For more than three decades, Dr. Karel Dicke has been recognized worldwide for developing innovative cancer treatments both in the academic and private setting. The focus of his practice is long-term survival with quality of life. State-of-the-art tests are used to establish individualized treatment based on genetic profiling of each patient’s tumor. This approach is being used in solid tumors such as breast, lung, gastric, pancreas, colon, ovarian, brain cancers and melanoma. A pioneer in high-dose chemotherapy with autologous stem cell transplantation, Dr. Dicke has also developed successful treatment plans for lymphoma, multiple myeloma and leukemia.

Location – Main Campus
906 W. Randol Mill Rd., Arlington, Texas 76012
Phone: 817-261-4906, Fax: 817-543-4671

Honors and Awards

  • Founding member of the Society of Experimental Hematology, 1970
  • Corresponding member of the Royal Dutch Academy of Sciences appointed by Her Majesty Queen Beatrix, 1982
  • Founding member of the American Society of Blood and Marrow Transplantation, 1993

Educational Background

  • M.D. – Leiden University Medical School, Leiden, The Netherlands
  • Ph.D. – Leiden University “cum laude” in cell biology, Leiden, The Netherlands